News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.

Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.

Company News for Nov 13, 2024 [Yahoo! Finance]

Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View [Yahoo! Finance]

11/12/2024

07:30 am

rgen

1.6%

BEAT

7/30/2024

07:30 am

rgen

14.1%

IN-LINE

5/1/2024

07:30 am

rgen

-1.0%

MISS

2/21/2024

07:30 am

rgen

7.2%

IN-LINE

Form 4 REPLIGEN CORP For: Nov 21 Filed by: Hunt Anthony

Form 144 REPLIGEN CORP Filed by: Hunt Anthony

Form 4 REPLIGEN CORP For: Nov 20 Filed by: Garland Jason K

Form 4 REPLIGEN CORP For: Nov 20 Filed by: Loeillot Olivier

Form 4 REPLIGEN CORP For: Nov 19 Filed by: MUIR GLENN P

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}